BGI Genomics Co., Ltd.
SZSE:300676.SZ
46.6 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| 93.682 | 809.443 | 1,477.699 | 2,102.052 | 278.519 | 407.844 | 423.686 | 350.017 | 272.055 | 58.53 | 172.668 | 85.354 |
| Depreciation & Amortization
| 436.836 | 453.035 | 370.601 | 302.331 | 241.076 | 169.02 | 112.978 | 94.504 | 88.544 | 91.002 | 41.005 | 19.502 |
| Deferred Income Tax
| 24.938 | 10.365 | -34.519 | -85.202 | 17.422 | -20.647 | -10.682 | -2.562 | 9.17 | 0 | 0 | 0 |
| Stock Based Compensation
| 122.81 | 0 | 0 | 95.96 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -479.676 | -1,485.895 | 537.081 | 956.345 | -397.283 | -609.832 | -315.358 | -173.156 | -24.719 | -173.359 | -189.986 | -39.324 |
| Accounts Receivables
| 736.488 | -1,059.597 | 254.154 | -471.963 | -421.609 | -585.918 | -278.217 | -250.641 | -110.249 | -125.265 | -145.009 | -338.831 |
| Inventory
| 103.782 | 46.255 | 169.935 | -603.699 | -101.065 | -103.324 | -64.988 | 37.807 | -24.34 | -19.673 | -36.902 | -9.377 |
| Accounts Payables
| -1,344.884 | -482.918 | 147.511 | 2,117.209 | 107.969 | 102.474 | 38.529 | 45.574 | 110.445 | 0 | 0 | 0 |
| Other Working Capital
| -583.458 | 10.365 | -34.519 | -85.202 | 17.422 | -506.508 | -250.37 | -210.963 | -0.379 | -153.686 | -153.084 | -29.947 |
| Other Non Cash Items
| 357.926 | 326.584 | 90.752 | 231.206 | 101.943 | 47.655 | 5.265 | -37.292 | -7.198 | 15.663 | 13.015 | 6.957 |
| Operating Cash Flow
| 408.768 | 136.379 | 2,476.132 | 3,602.693 | 224.255 | 14.687 | 226.571 | 234.074 | 328.683 | -8.164 | 36.702 | 72.489 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -1,236.385 | -1,266.62 | -383.52 | -301.153 | -626.439 | -678.126 | -291.33 | -246.007 | -177.261 | -556.254 | -284.877 | -61.889 |
| Acquisitions Net
| 2.716 | 1.145 | 5.905 | 4.039 | 1.3 | -31.836 | 2.455 | 40.262 | -27.601 | -14.351 | -31.928 | 0 |
| Purchases Of Investments
| -4,095.787 | -2,562.514 | -4,198 | -3,938.238 | -247.784 | -161.361 | -84.328 | -86.918 | -69.452 | -19.228 | -0.4 | 0 |
| Sales Maturities Of Investments
| 3,572.324 | 3,239.313 | 2,303.204 | 4,431.515 | 8.432 | 81.104 | 57.243 | 76.407 | 46.824 | 0.488 | 1.423 | 0 |
| Other Investing Activites
| 6.392 | 5.104 | -19.639 | -2.187 | 21.827 | 1,292.217 | -76.807 | 294.36 | -1,741.857 | 53.952 | 18.564 | 11.5 |
| Investing Cash Flow
| -1,750.741 | -583.573 | -2,292.05 | 193.976 | -842.665 | 501.998 | -392.767 | 78.104 | -1,969.347 | -535.393 | -297.218 | -50.39 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -12 | -693.5 | -586.996 | -25.265 | -200.591 | -8 | -5 | -8.129 | -34.47 | -3.47 | -1.95 | -18 |
| Common Stock Issued
| 82.851 | 64.062 | 26.105 | 482.32 | -197.216 | 0 | -14.12 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -363.33 | -26.105 | -482.32 | -3.375 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -413.914 | -143.47 | -144.87 | -40.01 | -40.01 | -200.321 | -108.53 | -82.932 | -0.77 | -0.298 | -0.145 | -0.628 |
| Other Financing Activities
| -89.826 | -34.643 | 1,802.083 | 1,237.982 | 789.199 | -279.841 | 481.079 | -2.211 | 1,686.029 | 739.939 | 226.494 | 289.497 |
| Financing Cash Flow
| -266.882 | -1,194.537 | 1,037.307 | 1,150.428 | 348.007 | -488.162 | 372.549 | -93.272 | 1,650.789 | 736.17 | 224.398 | 270.869 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 32.822 | 279.379 | -139.909 | -262.515 | 5.214 | 15.699 | -8.351 | 13.133 | -1.963 | 0.043 | -0.199 | -0.25 |
| Net Change In Cash
| -1,576.033 | -1,362.352 | 1,081.48 | 4,684.581 | -265.189 | 44.222 | 198.002 | 232.039 | 8.163 | 192.657 | -36.318 | 292.719 |
| Cash At End Of Period
| 3,555.141 | 5,129.192 | 6,491.544 | 5,410.064 | 725.484 | 990.673 | 946.45 | 748.448 | 516.41 | 508.247 | 315.591 | 351.909 |